Pharmaceutical Research

, Volume 27, Issue 6, pp 1092–1102 | Cite as

Dietary Grape Seed Proanthocyanidins Inhibit UVB-Induced Cyclooxygenase-2 Expression and Other Inflammatory Mediators in UVB-Exposed Skin and Skin Tumors of SKH-1 Hairless Mice

  • Som D. Sharma
  • Santosh K. KatiyarEmail author
Research Paper



The purpose of this study was to determine the chemopreventive mechanism of dietary grape seed proanthocyanidins (GSPs) against ultraviolet (UV) radiation-induced skin tumor development in mice.


Six-to-seven-week-old SKH-1 hairless mice were subjected to photocarcinogenesis protocol, and exposed to UVB radiation (180 mJ/cm2) three times/week for 24 weeks. Mice were fed a standard AIN76A control diet with or without supplementation with grape seed proanthocyanidins (GSPs; 0.2% or 0.5%, w/w). At the termination of the experiment, mice were sacrificed, and skin and skin tumor samples were harvested and subjected to the analysis of biomarkers related to inflammation using immunostaining, western blot analysis, ELISA and real-time PCR.


Dietary GSPs inhibited UVB-induced infiltration of proinflammatory leukocytes and the levels of myeloperoxidase, cyclooxygenase-2 (COX-2), prostaglandin (PG) E2, cyclin D1 and proliferating cell nuclear antigen (PCNA) in the skin and skin tumors compared to non-GSPs-treated UVB irradiated mouse skin and skin tumors. GSPs also significantly inhibited the levels of proinflammatory cytokines, tumor necrosis factor-α (P < 0.01), IL-1β (P < 0.001) and IL-6 (P < 0.001), in UVB-exposed skin and skin tumors.


The results from this study clearly suggest that dietary GSPs inhibit photocarcinogenesis in mice through the inhibition of UVB-induced inflammation and mediators of inflammation in mouse skin.


chemoprevention COX-2 grape seed proanthocyanidins skin cancer ultraviolet radiation 









proliferating cell nuclear antigen


prostaglandin E2


tumor necrosis factor-α



This work was financially supported by the Veterans Administration Merit Review Award (S.K.K.).


  1. 1.
    Housman TS, Feldman SR, Williford PM, Fleischer Jr AB, Goldman ND, Acostamadiedo JM. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48:425–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Katiyar SK. Oxidative stress and photocarcinogenesis: strategies for prevention. In: Singh KK, editor. Oxidative stress, disease and cancer. London: Imperial College; 2006. p. 933–64.CrossRefGoogle Scholar
  3. 3.
    Katiyar SK, Matsui MS, Mukhtar H. Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo: An immunohistochemical analysis of both epidermis and dermis. Photochem Photobiol. 2000;72:788–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Katiyar SK. Interleukin-12 and photocarcinogenesis. Toxicol Appl Pharmacol. 2007;224:220–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Black AK, Greaves MW, Hensby CN, Plummer NA. Increased prostaglandins E2 and F2alpha in human skin at 6 and 24 h after ultraviolet B irradiation (290–320 nm). Br J Clin Pharmacol. 1978;5:431–6.PubMedGoogle Scholar
  6. 6.
    Rivas JM, Ullrich SE. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J Leukoc Biol. 1994;56:769–75.PubMedGoogle Scholar
  7. 7.
    Mukhtar H, Elmets CA. Photocarcinogenesis: mechanisms, models and human health implications. Photochem Photobiol. 1996;63:355–447.CrossRefGoogle Scholar
  8. 8.
    Meeran SM, Akhtar S, Katiyar SK. Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Invest Dermatol. 2009;129:1258–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Yamakoshi J, Saito M, Kataoka S, Kikuchi M. Safety evaluation of proanthocyanidins-rich extract from grape seeds. Food Chemical Toxicol. 2002;40:599–607.CrossRefGoogle Scholar
  10. 10.
    Shi J, Yu J, Pohorly JE, Kakuda Y. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food. 2003;6:291–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Prieur C, Rigaud J, Cheynier V, Moutounet M. Oligomeric and polymeric procyanidins from grape seeds. Phytochemistry. 1994;36:781–9.CrossRefGoogle Scholar
  12. 12.
    Silva RC, Rigaud J, Cheynier V, Chemina A. Procyanidin dimers and trimers from grape seeds. Phytochemistry. 1991;30:1259–64.CrossRefGoogle Scholar
  13. 13.
    Mantena SK, Katiyar SK. Grape seed proanthocyanidins inhibit UV radiation-induced oxidative stress and activation of MAPK and NF-κB signaling in human epidermal keratinocytes. Free Rad Biol Med. 2006;40:1603–14.CrossRefPubMedGoogle Scholar
  14. 14.
    Sharma SD, Meeran SM, Katiyar SK. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-κB signaling in in vivo SKH-1 hairless mice. Mol Cancer Ther. 2007;6:995–1005.CrossRefPubMedGoogle Scholar
  15. 15.
    Nandakumar V, Singh T, Katiyar SK. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett. 2008;269:378–87.CrossRefPubMedGoogle Scholar
  16. 16.
    Mittal A, Elmets CA, Katiyar SK. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis. 2003;24:1379–88.CrossRefPubMedGoogle Scholar
  17. 17.
    Mantena SK, Baliga MS, Katiyar SK. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis. 2006;27:1682–91.CrossRefPubMedGoogle Scholar
  18. 18.
    Vayalil PK, Mittal A, Katiyar SK. Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NFκB. Carcinogenesis. 2004;25:987–95.CrossRefPubMedGoogle Scholar
  19. 19.
    Meeran SM, Katiyar SK. Grape seed proanthocyanidins promote apoptosis in human epidermoid carcinoma A431 cells through alterations in Cdki-Cdk-cyclin cascade, loss of mitochondrial membrane potential, caspase-3 activation. Exp Dermatol. 2007;16:405–15.CrossRefPubMedGoogle Scholar
  20. 20.
    Bagchi D, Bagchi M, Stohs S, Ray SD, Sen CK, Preuss HG. Cellular protection with proanthocyanidins derived from grape seeds. Ann NY Acad Sci. 2002;957:260–70.CrossRefPubMedGoogle Scholar
  21. 21.
    Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Meeran SM, Vaid M, Punathil T, Katiyar SK. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7, 12-dimethylbenz(a)anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis. 2009;30:520–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H. Prevention of UVB-induced immunosuppression in mice by green tea polyphenol (−)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis. 1999;20:2117–24.CrossRefPubMedGoogle Scholar
  24. 24.
    Meeran SM, Punathil T, Katiyar SK. Interleukin-12-deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors. J Invest Dermatol. 2008;128:2716–27.CrossRefPubMedGoogle Scholar
  25. 25.
    DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther. 1992;54:63–128.CrossRefPubMedGoogle Scholar
  26. 26.
    Vanderveen EE, Grekin RC, Swanson NA, Kragballe K. Arachidonic acid metabolites in cutaneous carcinomas. Arch Dermatol. 1986;122:407–12.CrossRefPubMedGoogle Scholar
  27. 27.
    Katiyar SK, Agarwal R, Wood GS, Mukhtar H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7, 12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res. 1992;52:6890–7.PubMedGoogle Scholar
  28. 28.
    Katiyar SK, Korman NJ, Mukhtar H, Agarwal R. Protective effects of Silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst. 1997;89:556–66.CrossRefPubMedGoogle Scholar
  29. 29.
    Meeran SM, Mantena SK, Elmets CA, Katiyar SK. (−)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res. 2006;66:5512–20.CrossRefPubMedGoogle Scholar
  30. 30.
    Wang ZY, Huang MT, Ferraro T, Wong CQ, Lou YR, Reuhl K, et al. Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res. 1992;52:1162–70.PubMedGoogle Scholar
  31. 31.
    Katiyar S, Elmets CA, Katiyar SK. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem. 2007;18:287–96.CrossRefPubMedGoogle Scholar
  32. 32.
    Langenbach R, Loftin CD, Lee C, Tiano H. Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann N Y Acad Sci. 1999;889:52–61.CrossRefPubMedGoogle Scholar
  33. 33.
    Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol. 2000;156:545–53.PubMedGoogle Scholar
  34. 34.
    Marks F, Fürstenberger G, Müller-Decker K. Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism. Recent Results Cancer Res. 1999;151:45–67.PubMedGoogle Scholar
  35. 35.
    Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18:7908–16.CrossRefPubMedGoogle Scholar
  36. 36.
    Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 1998;19:723–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Athar M, An KP, Morel KD, Kim AL, Aszterbaum M, Longley J, et al. Ultraviolet B (UVB)-induced COX-2 expression in murine skin: an immunohistochemical study. Biochem Biophys Res Commun. 2001;280:1042–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog. 2003;38:49–58.CrossRefPubMedGoogle Scholar
  39. 39.
    Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis. 1999;20:1939–44.CrossRefPubMedGoogle Scholar
  40. 40.
    Scott KA, Moore RJ, Arnott CH, East N, Thompson RG, Scallon BJ, et al. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol Cancer Ther. 2003;2:445–51.PubMedGoogle Scholar
  41. 41.
    Tron VA, Rosenthal D, Sauder DN. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J Invest Dermatol. 1988;90:378–81.CrossRefPubMedGoogle Scholar
  42. 42.
    Stanley PL, Steiner S, Havens M, Tramposch KM. Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol. 1991;4:262–71.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Birmingham Veteran Affairs Medical CenterBirminghamUSA
  2. 2.Department of DermatologyUniversity of AlabamaBirminghamUSA

Personalised recommendations